A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants

A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants

Conditions: Healthy Participants
Interventions: Drug: Elecoglipron Reference Formulation Dose A; Drug: Elecoglipron Test formulation 1 Dose A; Drug: Elecoglipron Reference Formulation Dose B; Drug: Elecoglipron Test formulation 1 Dose B; Drug: Elecoglipron Test formulation 2 Dose A; Drug: Elecoglipron Test formulation 2 Dose B
Sponsors: AstraZeneca
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 24, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments